Trial intelligence / Profile preview

Alprazolam vs placebo in IBS patients with insomnia – fMRI and HPA axis study

ChiCTR2200055168Phase 4Recruiting

Sponsor
Union Hospital of Huazhong University of Science and Technology
Start
Sep 2021
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, open-label trial in irritable bowel syndrome (IBS) and Insomnia comparing Alprazolam arm with Placebo arm (2 arms). Primary endpoints: Functional magnetic resonance imaging of the brain, Serum cortisol and 1 more. Started Sep 2021; status: recruiting.

02

Drugs

alprazolam
03

Conditions

irritable bowel syndrome (IBS)Insomnia

Beyond the preview

Go deeper on ChiCTR2200055168.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2200055168.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call